Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

MedWellAI (MWAI) EBIAT (2016 - 2025)

MedWellAI (MWAI) has disclosed EBIAT for 11 consecutive years, with -$287519.0 as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 12.37% to -$287519.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.3 million, a 36.56% increase, with the full-year FY2025 number at -$2.9 million, up 74.4% from a year prior.
  • EBIAT was -$287519.0 for Q4 2025 at MedWellAI, up from -$653607.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $1.3 million in Q3 2021 to a low of -$22.1 million in Q2 2023.
  • A 5-year average of -$3.2 million and a median of -$753350.0 in 2022 define the central range for EBIAT.
  • Biggest YoY gain for EBIAT was 446.59% in 2021; the steepest drop was 3630.14% in 2021.
  • MedWellAI's EBIAT stood at -$515261.0 in 2021, then plummeted by 48.2% to -$763597.0 in 2022, then surged by 52.91% to -$359564.0 in 2023, then increased by 8.75% to -$328094.0 in 2024, then increased by 12.37% to -$287519.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EBIAT are -$287519.0 (Q4 2025), -$653607.0 (Q3 2025), and -$743103.0 (Q2 2025).